| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,733,989 |
|
|
|
Indirect Value
|
$270,467 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$24,004,456 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-08 |
4 |
AS |
$724.33 |
$239,780 |
D/D |
(325) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-11 |
4 |
AS |
$729.76 |
$1,366,821 |
D/D |
(1,862) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-04-08 |
4 |
D |
$736.21 |
$4,518,857 |
D/D |
(6,138) |
30,606 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-17 |
4 |
AS |
$739.50 |
$264,741 |
D/D |
(358) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-14 |
4 |
D |
$743.78 |
$849,397 |
D/D |
(1,142) |
29,102 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-11-01 |
4 |
AS |
$750.00 |
$365,386 |
D/D |
(482) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-10-31 |
4 |
D |
$751.24 |
$1,140,382 |
D/D |
(1,518) |
29,226 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
28,991 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-02 |
4 |
AS |
$756.50 |
$461,564 |
D/D |
(610) |
28,744 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-01 |
4 |
D |
$760.35 |
$1,437,062 |
D/D |
(1,890) |
29,354 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
AS |
$764.50 |
$564,966 |
D/D |
(739) |
32,105 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2022-12-08 |
4 |
D |
$768.54 |
$1,737,669 |
D/D |
(2,261) |
29,483 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-03 |
4 |
D |
$774.29 |
$1,740,604 |
D/D |
(2,248) |
32,857 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-02-06 |
4 |
AS |
$783.05 |
$593,238 |
D/D |
(752) |
32,105 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-28 |
4 |
AS |
$818.81 |
$829,233 |
D/D |
(1,007) |
31,922 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-27 |
4 |
AS |
$819.47 |
$150,372 |
D/D |
(183) |
32,929 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-03-27 |
4 |
D |
$825.17 |
$2,304,700 |
D/D |
(2,793) |
33,112 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-08 |
4 |
D |
$843.79 |
$854,759 |
D/D |
(1,013) |
30,686 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-08-23 |
4 |
S |
$844.00 |
$188,212 |
D/D |
(223) |
31,699 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-11 |
4 |
D |
$844.09 |
$2,718,814 |
D/D |
(3,221) |
27,465 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-12 |
4 |
D |
$856.71 |
$5,466,667 |
D/D |
(6,381) |
21,084 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-13 |
4 |
D |
$871.12 |
$629,820 |
D/D |
(723) |
21,361 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-27 |
4 |
D |
$872.21 |
$472,738 |
D/D |
(542) |
21,569 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2023-12-28 |
4 |
D |
$884.88 |
$541,547 |
D/D |
(612) |
21,807 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2024-01-02 |
4 |
D |
$888.34 |
$373,991 |
D/D |
(421) |
22,036 |
0 |
- |
|
158 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
